Newsroom | 17699 results

SAN DIEGO--(BUSINESS WIRE)--Reproductive Medicine Associates (RMA), one of the nation's leading reproductive service providers and a pioneer in IVF research, today announced that Dr. Haley Glatthorn Genovese, a nationally recognized reproductive endocrinologist and former Jefferson-RMA fellow, has joined its Southern California clinical team. Dr. Genovese is now seeing patients at RMA’s San Diego clinic, located at 4510 Executive Drive, Suite 150. “As a San Diego native, born just across the st...

CORALVILLE, Iowa--(BUSINESS WIRE)--New enhancer protein expands IDT's market-leading portfolio of HDR reagents, empowering cell and gene therapy developers to accelerate discoveries...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will introduce pediatricians to GeneDx’s Infinity, the company’s proprietary dataset, at the American Academy of Pediatrics (AAP) National Conference & Exhibition taking place this weekend September 26 to 30 in Denver, CO. Infinity is the largest rare disease dataset and is one of the most powerful resources to accelerate diagnosis and fuel d...

SAN DIEGO & BOSTON--(BUSINESS WIRE)--Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights that advance precision health, in collaboration with the Lee Kun-hee Child Cancer and Rare Disease Project, today announced results from the STREAM Program (Strategic TREatment And Magic for pediatric cancers). The project, established through a donation from the family of the late Samsung Chairman Lee Kun-hee, is the first na...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important advancements across its programs in immunoglobulin A Nephropathy (IgAN), APOL1-mediated kidney disease (AMKD) and autosomal dominant polycystic kidney disease (ADPKD). These updates represent significant progress toward reaching the Company’s goal of bringing forward first-in-class or best-in-class therapies that target the underlying cause of these serious kidney diseases. Povetacicept...

SAN JOSE, Calif. & LA VISTA, Neb.--(BUSINESS WIRE)--Accellix™, een pionier op het gebied van geautomatiseerde flowcytometrie, en Streck, een erkend leider in kwaliteitscontrolematerialen voor flowcytometrie, hematologie en moleculaire diagnostiek, hebben een strategische samenwerking aangekondigd met de toevoeging van het Accellix Automated Cell Phenotyping Platform aan Streck's CD-Chex Plus® (RUO) controlesysteem. Het Accellix-platform is een compacte, volledig geautomatiseerde flowcytometer,...

SAN JOSÉ (California) y LA VISTA (Nebraska)--(BUSINESS WIRE)--Accellix™, pionera en citometría de flujo automatizada, y Streck, líder reconocido en materiales de control de calidad para citometrías de flujo, hematología y diagnóstico molecular, acaban de anunciar una colaboración estratégica con la incorporación de la plataforma de fenotipado celular automatizada Accellix al sistema de control CD-Chex Plus® (RUO) de Streck. La plataforma Accellix es un citómetro de flujo compacto y totalmente a...

SAN JOSE, Californie et LA VISTA, Nebraska--(BUSINESS WIRE)--Accellix™, pionnier de la cytométrie en flux automatisée, et Streck, leader reconnu des matériaux de contrôle qualité pour la cytométrie en flux, l'hématologie et les diagnostics moléculaires, ont annoncé une collaboration stratégique qui intègre la plateforme de phénotypage cellulaire automatisée Accellix au contrôle CD-Chex Plus® (RUO) de Streck. La plateforme Accellix est un cytomètre en flux compact entièrement automatisé, conçu p...

SAN JOSE, Calif. e LA VISTA, Neb.--(BUSINESS WIRE)--Accellix™, azienda pioniera nella citometria a flusso automatizzata, e Streck, leader riconosciuto nei materiali per il controllo della qualità nella citometria a flusso, diagnostica molecolare e in ematologia, hanno annunciato una collaborazione strategica con l'aggiunta della Accellix Automated Cell Phenotyping Platform al controllo CD-Chex Plus® (RUO) di Streck. La piattaforma Accellix è un citometro a flusso compatto interamente automatizz...

SAN JOSE, Kalifornien, und LA VISTA, Nebraska--(BUSINESS WIRE)--Accellix™, ein Pionier auf dem Gebiet der automatisierten Durchflusszytometrie, und Streck, ein renommierter Marktführer für Materialien für die Qualitätskontrolle in den Bereichen Durchflusszytometrie, Hämatologie und Molekulardiagnostik, haben eine strategische Zusammenarbeit bekannt gegeben. Im Rahmen dieser Zusammenarbeit soll die Automated Cell Phenotyping Platform von Accellix in die CD-Chex Plus® (RUO)-Kontrolle von Streck i...